Skip to content
ISO 13485 & 9001 certified
IVT Enzymes · Cat. no. GMP-BP-E02

RNase Inhibitor GMP-grade

Recombinant RNase inhibitor for protecting RNA workflows.

> 95% integrity
IVT product with inhibitor added
Strict residual control
GMP-grade purity
RNase Inhibitor GMP-grade

Product overview

RNase Inhibitor GMP-grade is a recombinant RNase inhibitor produced through recombinant expression and multi-step purification. It binds RNases with high affinity at a 1:1 ratio through noncovalent interactions, thereby inhibiting the activity of RNase A, RNase B, and RNase C without affecting the activity of RNase H or S1 Nuclease. This product does not inhibit phage RNA polymerases (SP6, T7, or T3), Taq, AMV, or MMLV. It also exhibits greater oxidation resistance and remains stable at lower DTT concentrations. It is suitable for preventing RNase contamination during IVT.

Available versions

Cat. no.Product nameFormulation
GMP-BP-E02-4KRNase Inhibitor GMP-grade
GMP-BP-E02-40KRNase Inhibitor GMP-grade
GMP-BP-E02-400KRNase Inhibitor GMP-grade

Features and applications

Features
  • (1) High purity
  • (2) High activity
  • (3) Strict residual control
Applications
  • During IVT, it is used to inhibit RNases in the environment and system, thereby preventing degradation of the synthesized mRNA.
  • mRNA storage and transport.
  • mRNA isolation and purification.
  • Reverse transcription and qPCR.
  • Applications requiring intact RNA.

Components

ComponentsCat. No.QuantityVolume
RNase Inhibitor GMP-grade (40 U/μL)GMP-BP-E02-4K4 KU100 μL
GMP-BP-E02-40K40 KU1 mL
GMP-BP-E02-400K400 KU10 mL

Performance data

1 Functional test

Description: RNA was used as the template, and qPCR was performed to verify the protective effect of RNase Inhibitor on the RNA template.

GMP-BP-E02 RNase Inhibitor GMP-grade: Figure 1 The results of the qPCR-based verification of the protective effect of RNase Inhibitor on RNA
Figure 1 The results of the qPCR-based verification of the protective effect of RNase Inhibitor on RNA

Conclusion: qPCR verification showed that adding RNase Inhibitor provided significant protection for RNA.

2 IVT test

Description: RNase Inhibitor was added to the IVT system, product integrity exceeded 95%.

GMP-BP-E02 RNase Inhibitor GMP-grade: Figure 2 The results of the capillary electrophoresis test on the IVT products that were added with RNase Inhibitor during the IVT.
Figure 2 The results of the capillary electrophoresis test on the IVT products that were added with RNase Inhibitor during the IVT.

Conclusion: Adding RNase Inhibitor during the IVT can result in a product with an integrity of over 95%.

Shipping and storage

ConditionRecommendation
StorageStore at -20±5°C. Mix thoroughly before use. Avoid repeated freeze-thaw cycles.
ShippingShip frozen on dry ice or with validated frozen cold-chain packaging that maintains the specified frozen storage condition.
HandlingAvoid repeated freeze-thaw cycles; mix thoroughly after thawing where applicable.

Need this product lyophilized, in bulk, or in a custom format?

The feasibility assessment is free of charge. Send the assay brief and target format.

Talk to an expert

Not ready for a quote? Discuss feasibility, formats, host systems or validation with the specialist behind this page — no sales script.

Topic detected: your enquiry

Reply within one business day from an application scientist. For pricing, COA or samples, use Request a quote instead.

Application scientistAssay integration & formats

Tell us what you want to discuss

Four fields. We route it to the right person and reply the way you prefer.

🔒 Used only to reply to this request. No newsletters. Privacy Policy

Need pricing, a COA or samples? Request a quote →

Quick Contact

* Your data is securely protected for essential communications only. We won’t share your details or send spam emails, Privacy Policy *